|
Site of cancer
|
Stage of tumor (N = 200)
|
Total (%)
|
|---|
|
Early (%)
|
Locally advanced (%)
|
Metastatic (%)
|
|---|
|
Lung
|
1 (0.5)
|
16 (8)
|
21 (10.5)
|
38 (19)
|
|
Gastric/GEJ
|
2 (1)
|
8 (4)
|
10 (5)
|
20 (10)
|
|
Head and Neck
|
1 (0.5)
|
14 (7)
|
19 (9.5)
|
34 (17)
|
|
Pancreatic
|
0
|
4 (2)
|
9 (4.5)
|
13 (6.5)
|
|
Ovarian
|
1 (0.5)
|
5 (2.5)
|
0
|
6 (3)
|
|
Esophageal
|
1 (0.5)
|
6 (3)
|
9 (4.5)
|
16 (8)
|
|
Germ Cell
|
3 (1.5)
|
1 (0.5)
|
9 (4.5)
|
13 (6.5)
|
|
Cervical/Vulvar
|
0
|
3 (1.5)
|
7 (3.5)
|
10 (5)
|
|
Bladder
|
0
|
5 (2.5)
|
7 (3.5)
|
12 (6)
|
|
Endometrial
|
1 (0.5)
|
3 (1.5)
|
0
|
4 (2)
|
|
Chloangiocarcinoma
|
0
|
2 (1)
|
2 (1)
|
4 (2)
|
|
Breast
|
0
|
3 (1.5)
|
3 (1.5)
|
6 (3)
|
|
Carcinoma of unknown primary (CUP)
|
0
|
6 (3)
|
2 (1)
|
8 (4)
|
|
Gall bladder/peri-ampullary
|
0
|
4 (2)
|
3 (1.5)
|
7 (3.5)
|
|
Lymphomaa
|
0
|
9 (4.5)
|
9 (4.5)
|
-
aLymphoma can only be classified into early or advanced stage
